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Integrin Activation by R-ras
Zhuohua Zhang,*² Kristiina Vuori,* signals, hence the term inside±out signaling (Chan et
Hong-Gang Wang,* John C. Reed,* al., 1992; Ginsberg et al., 1992; Hynes, 1992; O'Toole et
and Erkki Ruoslahti* al., 1994). Studies with compounds that initiate platelet
*La Jolla Cancer Research Center aggregation suggest that heterotrimeric G±proteins,
The Burnham Institute phospholipid metabolism, serine±threonine kinases,
10901 North Torrey Pines Road and tyrosine kinases are involved in the activation of
La Jolla, California 92037 the platelet integrin aIIbb3 (Smyth et al., 1993). A lipid
²Molecular Pathology Program that increases the binding function of the aMb2 and aLb2
School of Medicine integrins has been isolated from activated polymorpho-
University of California at San Diego nuclear leukocytes (Hermanowski-Vosatka et al., 1992).
La Jolla, California 92093 Moreover, injection of GTP analogs into Xenopus XTC
fibroblasts inhibits ruffling and increases cell spreading,
suggesting regulation of cell adhesion by small GTP-
Summary binding proteins (Symons and Mitchison, 1992). How-
ever, no specific intracellular signaling pathways, or pro-
Expression of a constitutively active R-ras converted teins directly involved in modulating integrin-mediated
two cell lines that grow in suspension into highly ad- cell adhesion, have been identified.
herent cells. There was little change in cell surface R-ras is a GTP-binding protein highly homologous to
expression of integrins, but attachment to surfaces H-ras protein, but with an extra 26 amino acids at the
coated with the integrin ligands was greatly enhanced.
amino terminus (Lowe et al., 1987). Previous studies
Cells transfected with activated R-ras bound integrin
have shown that R-ras promotes apoptosis induced byligands from solution with higher affinities and assem-
growth factor deprivation (Wang et al., 1995). However,bled severalfold more fibronectin matrix than control
R-ras induces neither cell proliferation nordifferentiationtransfectants. Introduction of a dominant negative
(Rey et al., 1994). It thus seems that R-ras may haveR-ras into adherent cells reduced the adhesiveness of
activity distinct from the transforming Ras proteins.the cells, indicating that endogenous R-ras can control
We show here that expression of a constitutively ac-the ligand-binding activity of integrins. These results
tive R-ras (R-ras38V) enhances cell adhesion to extracel-provide a mechanism for the modulation of integrin
lular matrix substrates, and that this increase in adhe-ligand-binding activity as well as a novel function for
sion results from enhanced integrin ligand-bindingR-ras.
activity. H-ras activated in an analogous manner
(H-ras12V) had no discernible effect on cell adhesion.Introduction
Blocking endogenous R-ras activity by expression of
dominant negative R-ras decreased integrin-mediatedAlterations in integrin-mediated cell adhesion to extra-
cell adhesion. Thus, R-ras may play a critical role incellular matrix arean essential regulatory process during
controlling integrin ligand-binding activity and cell±development, differentiation, and cell migration (Ruos-
extracellular matrix interactions.lahti, 1988; Hynes, 1992; Adams and Watt, 1993). Inte-
grin-mediated cell adhesion can be regulated at several
levels. One level is the regulation of the ligand-binding Results
activity of cell surface integrins. This type of regulation
provides a fast cell adhesion response to various exter- Constitutively Active R-ras38V Increases Cell
nal stimuli. Thus, integrin activation is necessary for Adhesion to Fibronectin and Vitronectin
platelet aggregation, leukocyte extravasation, and mac-
We initially noticed that 32D.3 mouse myeloid cells,
rophage activation (Smyth et al., 1993). Deactivation of
which grow in suspension, became highly adherent to
cell surface integrins has been observed in terminal dif-
culture substrate when transfected with a cDNA encod-ferentiation of keratinocytes (Adams and Watt, 1993)
ing constitutively active R-ras (32D/R-ras38V cells) (Figureand during neuronal development (Neugebauer and Rei-
1A). Cells transfected with vector alone (32D/c), withchardt, 1991).
wild-type R-ras cDNA (32D/R-raswt), or with constitu-Integrins can be activated by manipulating extracellu-
tively active H-ras cDNA (32D/H-ras12V) did not show thislar ions, such as Mg21, Ca21, and Mn21, and by treating
change. The R-ras38V cells also attached dramaticallycells with certain monoclonal anti-integrin antibodies
better to defined substrates consisting of fibronectin(Gailit and Ruoslahti, 1988; Frelinger et al., 1991; Hynes,
(Figure 1B) and vitronectin (data not shown), whereas1992; Arroyo et al., 1993). It has been suggested that
the other transfectants attached poorly to these sub-this type of integrin modulation is caused by a direct
strates. These results indicate that constitutively activeconformational change of the integrin molecule, and
R-ras enhances cell adhesion to extracellular matrixdoes not require cellular metabolism (Ginsberg et al.,
substrates.1992).
To determine whether R-ras38V would enhance the ad-The molecular mechanisms of physiological integrin
hesion of cells other than the 32D.3 cells, R-ras cDNAsactivation are poorly understood. Integrin cytoplasmic
encoding the R-ras38V and R-raswt proteins were cloneddomains play a role in the affinity modulation, sug-
gesting that the process is regulated by intracellular under the ZnCl2-inducible metallothionein promoter into
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Figure 1. Expression of R-ras38V Increases
Myeloid Cell Adhesion
(A) Morphology of 32D.3 cells expressing
R-ras variants or H-ras12V. The cells were
grown in a-MEM medium plus 10% fetal calf
serum in the presence of 250 mg/ml G418,
and photographed under phase contrast mi-
croscopy 12 hr after splitting. Representative
clones of cells transfected with vector alone
(32D/c), or expressing wild-type R-ras (32D/
R-raswt), constitutively active R-ras (32D/R-
ras38V), and constitutively active H-ras (32D/H-
ras12V) are shown. Some of the cells in panels
32D/c, 32D/R-raswt, and 32D/H-ras12V are
floating in the media, therefore appearing out
of focus.
(B) Quantitation of 32D.3 cell attachment.
Cells expressing R-ras variants or H-ras12V
were seeded onto plates coated with various
concentrations of fibronectin. After allowing
cells to attach for 40 min at 37oC, the extent
of cell adhesion was quantitated as described
in Experimental Procedures.
(C) Expression of R-ras variants in U937 cells.
Stable transfectants of R-raswt (U937/R-raswt),
R-ras38V (U937/R-ras38V), and vector alone
(U937/pML1) were tested by immunoblotting
for R-ras expression level before and after induction with 1.5 mM ZnCl2 for 10 hr. The same membrane was stripped and blotted by a
monoclonal antibody against b-tubulin (Sigma) as a control for protein loading.
(D) Quantitation of U937 cell attachment to fibronectin. U937/pML1, U937/R-raswt, and U937/R-ras38V cells were either induced by 1.5 mM
ZnCl2 (closed symbols), or cultured without ZnCl2 (open symbols) for 10 hr, and processed for cell attachment assay as described in (B).
the pML1 vector (Lukashev et al., 1994), and introduced with a peptide that inhibits the a4b1 integrin (SLIDIP;
Koivunen et al., 1993). The SLIDIP peptide alone partiallyinto the human myeloid cell line, U937. Cell attachment
assay with a mixture of stable transfectants demon- inhibited cell attachment on fibronectin, and had no ef-
fect on cell attachment on vitronectin. The 32D/R-ras38Vstrated that the R-ras38V transfectants (U937/R-ras38V),
when induced with ZnCl2, attached to fibronectin better cells, therefore, appear to attach to fibronectin through
the a4b1 and the a5b1 integrins. These results indicatethan the other transfectants, whether these were in-
duced or not (Figure 1D). The expression level of R-ras38V that cell adhesion mediated by different integrins can
be affected by R-ras38V in 32D.3 cells.in the U937/R-ras38V cells was lower than that of R-raswt
in the U937/R-raswt cells (Figure 1C), indicating that dif-
ferences in the expression levels of the R-ras variants R-ras38V Increases Cell Adhesion by Activating
Integrins on the Cell Surfacedid not explain the differences in cell attachment. Wild-
type R-ras did not alter cell adhesion, presumably Possible reasons for the enhanced cell attachment by
the R-ras38V- expressing cells include increased expres-because it remained inactive in these cells. None of
the U937 transfectants adhered to vitronectin-coated sion of cell surface integrins or increased activity of pre-
existing integrins. Fluorescence-activated cell sortingdishes; in agreement with this, no vitronectin receptors
were detected in these cells by immunoprecipitation
(data not shown). These results demonstrate that active
R-ras has the ability to increase cell adhesion to matrix
proteins in both murine and human cells, provided that
the cells have the appropriate receptors.
Activated R-ras (R-ras38V) Increases Cell
Adhesion Mediated by Different Integrins
We next used peptides capable of preventing integrin-
mediated cell adhesion to examine the receptors in-
volved in the R-ras38V-induced increase of cell adhesion.
GRGDSP peptide, which inhibits cell adhesion mediated
by the av integrins and the a5b1 integrin (Ruoslahti, 1988),
inhibited 32D/R-ras38V cell attachment tovitronectin (Fig-
Figure 2. Inhibition of Cell Attachment With Peptidesure 2), as did a polyclonal anti-avb3 antibody (data not
The 32D/R-ras38V were seeded on plates coated with either 15 mg/shown). Thus, an RGD-dependent av integrin, presum-
ml fibronectin (closed bars) or with 15 mg/ml vitronectin (open bars)ably avb3, mediates the attachment of these cells to in a-MEM in the absence (plus) or presence of 1 mg/ml GRGDSP
vitronectin. Fibronectin attachment of the 32D/R-ras38V (RGD), 1 mg/ml GRGESP (RGE), 1 mg/ml SLIDIP (IDI), or 1 mg/ml
cells was not detectably inhibited by the GRGDSP pep- GRGDSP plus 1 mg/ml SLIDIP (RGD 1 IDI). Uncoated wells were
the negative control (minus).tide (Figure 2), but this peptide inhibited synergistically
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Figure 4. FACS Histogram Showing Binding of PAC1 Antibody to
CHO2b3a Transfectants
Binding of the activation-dependent antibody PAC1 to CHO2b3a/c,
CHO2b3a/R-raswt, CHO2b3a/R-ras38V, and CHO2b3a/H-ras12V cells
was determined by subjecting cells to FACS analysis as described
in Experimental Procedures. The results of PAC1 binding are shown
as a light line in the figure. CHO2b3a/R-raswt cells stained in the
absence of PAC1 antibody were used as the negative control, which
is shown by the dark line in the figure. The slight shift of the PAC1
peak in the CHO2b3a/c and CHO2b3a/R-raswt panels was not repro-
ducible.
low affinity state even though other integrins are active
Figure 3. FACS Analysis of Integrin Expression in 32D.3 Cells and
in these cells (O'Toole et al., 1991, 1994). Activation ofTheir Transfectants
the aIIbb3 integrin can be accomplished with certain anti-32D/c and 32D/R-ras38V cells were stained with (dark lines) or without
aIIbb3 antibodies or by genetically changing the cyto-(light lines) anti-mouse integrin monoclonal antibodies followed by
plasmic domain of the b3 subunit (O'Toole et al., 1991,FITC-labeled secondary antibodies and FACS analysis, as de-
scribed in Experimental Procedures. 1994). The activation can be assessed with a ligand-
mimic monoclonal antibody, PAC1, which binds only to
an active form of this integrin (Shattil et al., 1985).
CHO2b3a clones expressing similar levels of the vari-(FACS) analysis with monoclonal antibodies against
ous Ras proteins as determined by immunoblottingmouse integrin av, a4, a5, and b1 subunits indicated the
(data not shown) were generated and analyzed for PAC1presence of each of these subunits on the surface of
binding by FACS. All four CHO2b3a/R-ras38V clonesthe original 32D.3 cells, and showed that the integrin
bound PAC1, whereas two CHO2b3a/R-raswt clones,expression levels in these and the transfectant 32D/c
two CHO2b3a/H-ras12V-expressing clones, and two con-and 32D/R-ras38V cells were similar. Results with repre-
trol clones (CHO2b3a/c) did not. The results for a repre-sentative 32D/c and 32D/R-ras38V clones are shown in
sentative clone of each variant type are shown in Fig-Figure 3. Immunoprecipitation of integrin subunits from
ure 4. These results further demonstrate that R-ras38Vsurface-iodinated cells confirmed the expression of
increases cell adhesion by enhancing the ligand-bindingequal amounts of the av, a4, a5, and b1 subunits at the
activity of integrins that are already present on the cellcell surface of the 32D variants (data not shown), and
surface.further revealed the presence of the b3 subunit, also in
equal amounts, in the 32D/R-ras38V and control transfec- To investigate the possibility that R-ras would modu-
late integrin affinity, we tested cell binding of a fibronec-tants. The b6 subunit was not detected in these cells.
These results indicate that changes in integrin cell sur- tin 110 kDa fragment that contains the RGD cell attach-
ment site and binds to the a5b1 integrin (Pierschbacherface expression are not responsible for R-ras38V-induced
cell adhesion to matrixproteins, and suggest that activa- et al., 1981; Pytela et al., 1985). The 32D/R-ras38V cells
bound soluble 110 kDa fragment, whereas the bindingtion of integrins underlies the R-ras38V effect.
We next used a Chinese hamster cell line that ex- of the fragment to the 32D/c cells was only marginal
(Figure 5A). Scatchard analysis indicated a Kd for thepresses the aIIbb3 integrin (CHO2b3a; O'Toole et al.,
1991) to study the ability of R-ras to convert an inactive 110 kDa fragment binding to the 32D/R-ras38V cells of
250 6 20 nM and the number of receptors per cell wasintegrin to an active one. The CHO2b3a cells express
the aIIbb3 integrin on the cell surface, but it remains in a 6.2 6 0.5 3 104 (Figure 5B). The affinity we determined
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cDNA into CHO-K1 cells. Transfectants were plated on
fibronectin-coated coverslips, stained, and analyzed mi-
croscopically for b-galactosidase expression and cell
adhesion and spreading. The results showed that 61%
of CHO/R-raswt and 59% of CHO/R-ras38V cells were
firmly attached and spread. In contrast, the CHO/R-
ras43N cells had fewer than 5% spread cells under the
same conditions (Figure 6).Similar results were obtained
by plating the cells on vitronectin-coated coverslips
(data not shown). We also used U937 cells, which grow
in suspension, to generate stable expressors of R-ras43N;
this control indicated that R-ras43N is not inherently toxic
to cells (data not shown). Because CHO cell adhesion
to fibronectin and vitronectin is known to be integrin
mediated (Giancotti and Ruoslahti, 1990; Zhang et al.,
1993), we conclude that expression of dominant nega-
tive R-ras reduces integrin-mediated cell adhesion.
Expression of R-ras38V Results in Increased
Fibronectin Matrix Assembly
in CHO2b3a Cells
We next asked whether integrin activation by R-ras
might result in enhancement of integrin functions other
than mediation of cell adhesion. Fibronectin matrix as-
sembly is one such function (Giancotti and Ruoslahti,
1990; Wu et al., 1993). The CHO2b3a cells provided a
suitable system to study the effect of R-ras on matrix
assembly, because the activation of the aIIbb3 integrin
with antibodies has been shown to increase greatly the
fibronectin matrix deposition in these cells (Wu et al.,
1995). Immunofluorescence staining with anti-fibronec-
tin antibodies showed fibronectin fibrils only on theFigure 5. Binding of Soluble Fibronectin Cell Attachment Fragment
to 32D.3 Transfectants CHO2b3a/R-ras38V cells (data not shown). To study the
The 32D/c and 32D/R-ras38V cells were incubated with a 125I-labeled matrix assembly quantitatively, monolayersof CHO2b3a
110 kDa fibronectin fragment with various concentrations of unla- cells expressing R-ras variants were incubated with
beled 110 kDa fragment for 1 hr. The amount of labeled 110 kDa 125I-labeled fibronectin for 12 hr, and the amount of
fragment bound to the cells was quantitated (A). (B) shows a dis-
radiolabeled fibronectin incorporated into detergent-in-placement curve and Scatchard plot (inset) obtained with the 32/
soluble matrix was measured (McKeown-Longo andR-ras38V cells as described in Experimental Procedures.
Mosher, 1985). Among the transfectants, the CHO2b3a/
R-ras38V cells were the most efficient in assembling ma-was in agreement with previous measurements of inte-
trix; they deposited approximately 7- to 10-fold moregrin affinity for fibronectin (Akiyama and Yamada, 1985).
fibronectin into the matrix than either the controlThe low binding precluded determination of affinity of
CHO2b3a/c cells, or the cells transfected with the otherthe 32D/c cells for the 110 kDa fibronectin fragment.
constructs (Figure 7).However, since the antibody results presented above
These results show that R-ras38V enhances fibronectinshow that the 32D/R-ras38V and control cells express the
matrix assembly in CHO2b3a cells; thus, R-ras also ap-same level of a5b1 on the cell surface, the difference pears to be capable of enhancing the ability of integrinsshould be due to an increase of a5b1 affinity for fibronec- to support matrix assembly.tin from undetectable to the level measured in the
R-ras38V cells. Thus, R-ras38V modulates the ligand bind-
ing affinity of the a5b1 integrin in the 32D cells. Discussion
Our results show that an activated R-ras mutant,Dominant Negative R-ras (R-ras43N) Reduces
Integrin-Mediated Cell Adhesion R-ras38V, can induce ligand-binding activity in function-
ally inactive integrins, and that theactivity of theendoge-Because we found that activated R-ras enhanced li-
gand-binding activity, it seemed that inhibition of endog- nous R-ras protein is required for integrins to be main-
tained in an active state on the cell surface. Integrinenous R-ras activity might have the opposite effect.
Inhibition of R-ras can be accomplished with a dominant activation by R-ras38V is at least partly due to an increase
in ligand binding affinity and results in enhanced cellnegative R-ras mutant (R-ras43N; Spaargaren and
Bischoff, 1994). adhesion and fibronectin matrix assembly.
The biological function of R-ras is largely unknown.A transient transfection system was designed in which
a pCH110/b-galactosidase cDNA was transiently co- The same activated form of R-ras that we used in this
study has been found to have no transforming effect intransfected with an R-ras43N, an R-ras38V, or an R-raswt
Integrin Activation by R-ras
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Figure 7. Fibronectin Matrix Deposition by Cells Expressing Various
Ras Proteins
Quantitation of fibronectin matrix assembly in CHO2b3a cells
transfected with R-ras variants and H-ras12V. Confluent monolayers
of CHO2b3a/c, CHO2b3a/R-raswt, CHO2b3a/R-ras38V, and CHO2b3a/
H-ras12V clones were incubated with 125I-labeled fibronectin for 12
hr. The total amount of 125I-labeled fibronectin associated with a
deoxycholate-insoluble matrix was determined as described in Ex-
perimental Procedures.
apoptosis suppressor protein Bcl-2 under some circum-
stances (Fernandez-Sarabia and Bischoff, 1993), but
this is not universally seen in all cells (Wang et al., 1995).
Moreover, R-ras38V accelerates apoptosis that has been
induced by withdrawal of growth factors (Wang et al.,
1995). These properties are not shared by activated
H-ras. In addition, unlike H-ras, R-ras does not promote
PC12 cell differentiation, Xenopus oocyte maturation, or
enhance DNA synthesis (Reyet al.,1994). These findings
suggest that while R-ras may share some biochemical
activities with H-ras, it also works through pathways
distinct from those regulated by the transforming p21ras
proteins. Our finding that R-ras, but not H-ras, regulates
cell adhesion by modulating integrin activity provides
R-ras with a function distinct from those of the trans-
forming Ras proteins.Figure 6. Effect of Dominant Negative R-ras43N on Cell Adhesion
Two lines of evidence show that the enhancement ofCHO-K1 cells were transiently cotransfected with cDNAs coding
for R-ras variants and pUC18/b-galactosidase, and then plated in cell adhesion induced by R-ras is caused by modulation
serum-free a-MEM on coverslips that had been precoated with 15 of the activity of integrins already present on the cell
mg/ml fibronectin. After 90 min incubation at 37oC, the cells were surface. First, while the R-ras38V cells and control cells
stained as described in Experimental Procedures, and analyzed by expressed similar levels of integrins available to cell
microscope.
surface labeling, only the R-ras38V cells attached to ma-(A) Cell attachment to fibronectin. Cells expressing R-ras38V (R-ras38V)
trix protein. Second, ligand binding experiments withor R-ras43N (R-ras43N), identified as dark cells, are indicated by arrows.
the ligand-mimic PAC1 antibody and a fibronectin cell(B) Quantitation of cell spreading of the indicated transfectants.
attachment fragment showed increased binding ofMore than 100 blue cells were counted in each transfection.
(C) Each bar represents the average of data from two independent these ligands by the R-ras38V cells. PAC1 provides a
experiments. convenient tool for the analysis of the activity state of
the aIIbb3 integrin, because it mimics the binding charac-
teristics of the natural aIIbb3 ligand, fibrinogen (Shattil et
some cells and only a weak effect in others, compared al., 1985; Bennett et al., 1988), and does not bind aIIbb3
with H-ras (Lowe and Goeddel, 1987; Cox et al., 1994; mutants that are defective in fibrinogen binding (Gins-
berg et al.,1990). The binding of this antibody is believedSaez et al., 1994). R-ras has been reported to bind the
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to reflect the high affinity state of aIIbb3 (Ginsberg et al., been connected to integrin function; it promotes assem-
bly of focal adhesions and actin stress fibers (Ridley1992). However, because PAC1 is an immunoglobulin
M (IgM) antibody with five antigen binding sites, part or and Hall, 1992; Hall, 1994; Nobes and Hall, 1995). The
cytoskeletal changes mediated by Rho resemble theall of the increase in PAC1 binding could be due to a
change that favors multivalent binding. A rearrangement changes that result from integrin±extracellular matrix
interaction (McNamee et al., 1992). Rho also modifiesof integrins into clusters could promote multivalent
PAC1 binding, making the change in aIIbb3 activity one intracellular phosphatidylinositol 4,5-bisphosphate con-
centration by regulating phosphatidylinositol 4-phos-of avidity rather than affinity. Our use of the fibronectin
110 kDa cell attachment fragment does not suffer from phate 59 kinase in an adhesion-dependent manner
(Chong et al., 1994). These functions of Rho suggestthis limitation, because this fragment is monovalent in
integrin binding (Pierschbacher et al., 1981). The binding that it may be a downstream mediator in integrin signal-
ing. R-ras and Rho may affect cell adhesion in differentof this fragment to the 32D cells indicated a substantial
increase in the ligand binding affinity of the integrin that ways. R-ras regulates cell adhesion by activating inte-
grins, and is therefore involved in inside±out signaling.binds the 110 kDa fragment, presumably a5b1. Thus, the
R-ras38V-mediated activation of integrin is, at least partly, The Rho effects are a result of the binding of ligands to
integrins, and Rho may thus be a component in integrin-caused by an increase in integrin affinity; our results do
not exclude possible avidity changes, such as those mediated outside±in signaling.
Cells expressing the R-ras38V protein assembled in-that might be caused by integrin clustering.
Integrins can be activated from outside the cell creased amounts of fibronectin matrix. The aIIbb3 integrin
has recently been found to mediate fibronectin matrix(Hynes, 1992; Smyth et al., 1993). A well-studied exam-
ple is the enhanced fibrinogen binding by aIIbb3 when assembly in CHO2b3a cells that are treated with an
antibody capable of activating this integrin (Wu et al.,platelet aggregation is induced with agents such as
thrombin (Smyth et al., 1993). The close resemblance 1995). Prior to this, integrin a5b1 was the only integrin
shown to have the capacity to support fibronectin matrixbetween the aIIbb3 responses and the effect of activated
R-ras we observe suggests that activated endogenous assembly. However, tissues from mice lacking the a5b1
integrin can assemble fibronectin into extracellularR-ras protein may be responsible for the alteration of
integrin activity in platelet aggregation and other situa- matrix, suggesting that other receptors can substitute
for a5b1 in the matrix assembly (Yang et al., 1993). Intions inwhich integrins are activated. Thus, signals origi-
nating outside the cell may cause conversion of R-ras agreement with the results of Wu et al. (1995), we
find that the aIIbb3 integrin plays a role in fibronec-from the inactive GDP-bound form to the active GTP-
bound form, which then modulates integrin ligand-bind- tin matrix assembly by the CHO2b3a cells; inhibi-
tion of matrix assembly required the treatment of theing activity. Moreover, our finding that dominant nega-
tive R-ras decreased integrin-mediated cell adhesion R-ras38V-transfected CHO2b3a cells with antibodies
against both the a5b1 and aIIbb3 integrins (data notsuggests that endogenous R-ras is not only a possible
regulator of integrin activation, but that it may also main- shown). These data indicate that matrix assembly is
influenced by the activity state of the integrins that directtain the function of those integrins that are active under
basal conditions. matrix assembly, and that integrins activated by R-ras38V
gain biological functions other than cell adhesion ac-The exact mechanism of action for the dominant nega-
tive R-ras is not known, but it probably competitively tivity.
Oncogenic transformation often induces a loss ofinhibits the interaction between the endogenous R-ras
and a guanine nucleotide exchange factor; such a mech- fibronectin matrix (Ruoslahti and Giancotti, 1989) and
reduces integrin expression, especially that of a5b1anism of action has been proposed for dominant nega-
tive H-ras (Farnsworth and Feig, 1991; Stacey et al., (Plantefaber and Hynes, 1989). In some transformed
cells, however, there is a significant reduction in matrix1991). Physiological activation of GTP-binding proteins
is modulated by activating proteins that stimulate nucle- assembly without any concomitant reduction in fibro-
nectin synthesis or a loss of integrin expression on theotide exchange of R-ras, and by inhibiting proteins that
enhance GTP hydrolysis (GTPase-activating proteins cell surface (Vaheri and Ruoslahti, 1974; Akiyama et al.,
1990). Our findings raise the possibility that fibronectin[GAPs]). Sos1, a guanine nucleotide exchange factor
that controls the activity of p21ras, does not stimulate receptors might be inactive or incompletely active in
nucleotide exchange on R-ras, suggesting that R-ras some transformed cells. It will be interesting to see
may be regulated at least in part by a different set of whether the quantity or function of R-ras is altered upon
regulatory proteins than p21ras (Buday and Downward, oncogenic transformation.
1993). Possible GAPs for R-ras have been proposed
(Garrett et al., 1989; Rey et al., 1994; Yamamoto et al., Experimental Procedures
1995). It will be interesting to see whether these proteins
might display changes during integrin activation. Inte- Cells and Reagents
CHO-K1 cells were obtained from ATCC. U937 cells were providedgrins can be activated by treating cells with nonhydro-
by Dr. X. Zhang at La Jolla Cancer Research Foundation. CHO2b3alyzable guanine triphosphate analogs, which activate
cell line, which is a CHO cell line expressing integrin aIIbb3 on theGTP-binding proteins (Shattil and Brass, 1987; Symon
cell surface (O'Toole et al., 1991), was a gift from Dr. M. Ginsberg
and Mitchison, 1992). Our results may explain this obser- at The Scripps Research Institute. All cells were maintained in
vation; these compounds may function by activating a-modified Eagle's medium (a-MEM) supplemented with 10% fetal
endogenous R-ras. bovine serum. G418 (GIBCO BRL) was added into the medium for
32D.3 transfectants and CHO2b3a cells at 250 mg/ml.Rho is another small GTP-binding protein that has
Integrin Activation by R-ras
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Human plasma fibronectin was from the Finnish Red Cross and 1990; Vogel et al., 1993). Monoclonal antibodies P1E6 (anti-a2), P1B5
(anti-a3), P1D6 (anti-a5; Wayner et al., 1988), L230 (anti-av), and poly-vitronectin was purified as described(Yatohgo et al., 1988). Peptides
were synthesized at the Protein Chemistry Laboratory of the La clonal antisera against a4, a6, b1, b3, and b6 cytoplasmic domains
were used to analyze the integrin expression in U937 cells.Jolla Cancer Research Foundation. Precast Tris±glycine SDS±
polyacrylamide gels were from Novex. All other reagents were pur- Integrin expression on 32D cells was also analyzed by FACS
(Zhang et al., 1993). Monoclonal antibodies against mouse avchased from Sigma.
(H9.2B8), a4 (9C10), a5 (5H10±27), and b1 (9EG7) integrins and FITC-
labeled goat anti-rat IgG (for 9C10, 5H10±27, and 9EG7) and goatPlasmids
anti-hamster IgG (for H9.2B8) secondary antibodies were obtainedPlasmids pEXV-R-raswt and pEXV-R-ras38V containing R-ras cDNA
from PharMingen (San Diego, CA).sequences that encode R-raswt and R-ras38V proteins, and a eukaryo-
tic vector expressing H-ras12V under the control of the SV40 early
Cell Attachment Assaypromoter were provided by Dr. A. Hall at University College, London
The quantitative cell attachment assay and the use of antibodies(Rey et al., 1994). R-ras cDNA coding for the dominant negative
and peptides as inhibitors in it have been described previouslyR-ras43N protein was generated by PCR mutagenesis. cDNAs encod-
(Zhang et al., 1993).ing R-raswt and R-ras38V proteins were cloned into a Zn21-inducible
vector pML1 (Lukashev et al., 1994) at the EcoRI site. The plasmid
pCH110 containing a functional b-galactosidase gene is from Pha- PAC1 Binding
macia (Uppsala, Sweden). Monoclonal antibody PAC1 was obtained from Dr. S.J. Shattil at
The Scripps Research Institute, and PAC1 binding was analyzed
essentially as described (Peter and O'Toole, 1995). Cells were de-Transfection
tached with 5 mM EDTA in PBS and washed with 15 ml of modified32D.3 cells expressing either wild-type R-ras (R-raswt), active form
Tyrode's buffer followed by incubation with 100 ml of PAC1 at 10R-ras (R-ras38V), or active form H-ras (H-ras12V), and a control cell
mg/ml for 30 min on ice. After a wash with 15 ml of modified Tyrode'sline transfected with vector alone, were generated with electropora-
buffer, the cells were stained with 100 ml of FITC-conjugated anti-tion as described (Wang et al., 1995). Calcium phosphate transfec-
mouse IgM (Sigma) for 30 min on ice and analyzedby flow cytometry.tion was used with other cell lines (Zhang et al., 1993). U937 cells
transfected with various R-ras/pML1 plasmids were selected in me-
dium containing 400 U/ml hygromycin (Calbiochem, La Jolla, CA). Binding of Soluble Ligands to Cell Surface Integrins
Dead cells were removed with Histopaque (Sigma Diagnostics), and and Integrin Affinity Measurement
stable transfectants were isolated by limited dilution. A hygromycin- A cell-binding 110 kDa fibronectin fragment (Pierschbacher et al.,
resistance plasmid was cotransfected with a pEXV plasmid con- 1981) was iodinated (Morla and Ruoslahti, 1992), and its binding to
taining an R-raswt, an R-ras38V, an H-ras12V cDNA into the CHO2b3a the cells was quantitated as described (Zhang et al., 1993; Peter
cells. Transfectants were selected with 400 U/ml hygromycin, and and O'Toole, 1995). The homogeneity of thefragment was confirmed
clones were isolated with cloning rings. To generate control cell by gel electrophoresis prior to the iodination. The specific activity
lines, a pML1 plasmid and a hygromycin-resistance plasmid were of the labeled fragment was 2.9 3 109 mCi/mmol.
introduced into U937 and CHO2b3a cells, respectively. A pCH110
plasmid was transiently cotransfected with an R-ras43N, an R-ras38V, Fibronectin Matrix Assembly Assay
or an R-raswt cDNA into CHO-K1 cells. b-galactosidase activity was Matrix assembly assays were carried out using 125I-labeled fibronec-
assayed 48 hr after transfection, as described below. tin as described (McKeown-Longo and Mosher, 1985; Morla and
Ruoslahti, 1992).
Protein Analysis
The expression of R-ras protein was analyzed by immunoblotting Immunofluorescent Staining and Detection
with an anti-R-ras antibody (Wang et al., 1995). In brief, cells were of b-Galactosidase Activity
detached with trypsin/EDTA solution, washed once with PBS, and For fibronectin matrix staining, cells were grown to confluency on
lysed with RIPA buffer for 30 min on ice. After a 20 min centrifugation coverslips, washed, and fixed in 3.7% paraformaldehyde, 10 mM
at 16,0003g, supernatants were collected and protein concentra- sucrose in PBS (pH 7.4) for 30 min. The cultures were then stained
tions were measured by using the Bio-Rad protein staining kit with a rabbit anti-mouse fibronectin antiserum for 1 hr followed by
(Bio-Rad, CA). Lysates containing equal amounts of protein were Rho-labeled goat anti-rabbit IgG secondary antibody (Sigma). After
separated on 4%±20% precast Tris±glycine gels and proteins were antibody treatment, coverslips were mounted onto slides with Vec-
electroblotted onto Immobilon membranes. After blocking with 5% tashield mounting medium (Vector Laboratories, CA)and slides were
nonfat milk in PBS, the membranes were stained with anti-R-ras analyzed under fluorescent microscopy.
antibody (Wang et al., 1995) for 60 min at room temperature with To detect the b-galactosidase activity, transfected cells were de-
rotation. The membraneswere then washed with 0.05% Triton X-100 tached with trypsin/EDTA solution, washed twice with serum-free
in PBS, followed by staining with horseradish peroxidase± medium, plated on dishes precoated with 15 mg/ml fibronectin, and
conjugated goat anti-rabbit IgG secondary antibody (Sigma) for 45 incubated at 37oC for 90 min. The cells were then rinsed twice with
min at room temperature. Immunoreactive bands were detected PBS, fixed with 1% glutaraldehyde for 5 min, rinsed three times with
with enhanced chemiluminescence (ECL, Amersham) and quanti- PBS, and stained in X-Gal buffer (0.5 mg/ml 5-bromo-4-chloro-
tated with an LKB densitometer. Cells transfected with a vector 3-indoxyl b-galactoside, 3 mM K4Fe[CN]6±3H2O, 3 mM K3Fe[CN]6, 1
containing the selection marker alone (CHO2b3a/c) were used as a mM MgCl2, 10 mM KCl, and 0.1 M sodium phosphate buffer [pH
control, and protein loading was controlled by blotting the same 7.2]) at 378C overnight.
membrane with an anti-b-tubulin antibody.
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